ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer.

Autor: Centenera MM; University of Adelaide Medical School, Adelaide, SA, Australia.; Freemasons Foundation Centre for Men's Health, Adelaide, SA, Australia.; South Australian Health and Medical Research Institute, Adelaide, SA, Australia., Scott JS; University of Adelaide Medical School, Adelaide, SA, Australia.; Freemasons Foundation Centre for Men's Health, Adelaide, SA, Australia.; South Australian Health and Medical Research Institute, Adelaide, SA, Australia., Machiels J; Department of Oncology, Laboratory of Lipid Metabolism and Cancer, KU Leuven, Leuven, Belgium., Nassar ZD; University of Adelaide Medical School, Adelaide, SA, Australia.; Freemasons Foundation Centre for Men's Health, Adelaide, SA, Australia.; South Australian Health and Medical Research Institute, Adelaide, SA, Australia., Miller DC; University of Adelaide Medical School, Adelaide, SA, Australia.; Freemasons Foundation Centre for Men's Health, Adelaide, SA, Australia.; South Australian Health and Medical Research Institute, Adelaide, SA, Australia., Zinonos I; University of Adelaide Medical School, Adelaide, SA, Australia.; Basil Hetzel Institute, Queen Elizabeth Hospital, SA, Australia., Dehairs J; Department of Oncology, Laboratory of Lipid Metabolism and Cancer, KU Leuven, Leuven, Belgium., Burvenich IJG; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia., Zadra G; Dana-Farber Cancer Institute, Boston, Massachusetts., Chetta PM; Dana-Farber Cancer Institute, Boston, Massachusetts.; University of Milan, Milan, Italy., Bango C; Dana-Farber Cancer Institute, Boston, Massachusetts., Evergren E; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK., Ryan NK; University of Adelaide Medical School, Adelaide, SA, Australia.; South Australian Health and Medical Research Institute, Adelaide, SA, Australia., Gillis JL; University of Adelaide Medical School, Adelaide, SA, Australia.; South Australian Health and Medical Research Institute, Adelaide, SA, Australia., Mah CY; University of Adelaide Medical School, Adelaide, SA, Australia.; Freemasons Foundation Centre for Men's Health, Adelaide, SA, Australia.; South Australian Health and Medical Research Institute, Adelaide, SA, Australia., Tieu T; Drug Delivery, Disposition and Dynamics, Monash University, Parkville, VIC, Australia.; Commonwealth Scientific and Industrial Research Organisation (CSIRO), Clayton, VIC, Australia., Hanson AR; University of Adelaide Medical School, Adelaide, SA, Australia., Carelli R; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, New York., Bloch K; Department of Oncology, Laboratory of Lipid Metabolism and Cancer, KU Leuven, Leuven, Belgium., Panagopoulos V; University of Adelaide Medical School, Adelaide, SA, Australia.; South Australian Health and Medical Research Institute, Adelaide, SA, Australia., Waelkens E; Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium., Derua R; Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium., Williams ED; Australian Prostate Cancer Research Centre - Queensland, Queensland University of Technology (QUT), Princess Alexandra Hospital, Translational Research Institute, Brisbane, QLD, Australia., Evdokiou A; University of Adelaide Medical School, Adelaide, SA, Australia.; Basil Hetzel Institute, Queen Elizabeth Hospital, SA, Australia., Cifuentes-Rius A; Drug Delivery, Disposition and Dynamics, Monash University, Parkville, VIC, Australia., Voelcker NH; Drug Delivery, Disposition and Dynamics, Monash University, Parkville, VIC, Australia.; Commonwealth Scientific and Industrial Research Organisation (CSIRO), Clayton, VIC, Australia.; Melbourne Centre for Nanofabrication, Victorian Node of the Australian National Fabrication Facility, Clayton, VIC, Australia., Mills IG; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK., Tilley WD; University of Adelaide Medical School, Adelaide, SA, Australia.; Freemasons Foundation Centre for Men's Health, Adelaide, SA, Australia., Scott AM; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia.; Department of Medicine, University of Melbourne, Melbourne, VIC, Australia.; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC, Australia., Loda M; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, New York., Selth LA; University of Adelaide Medical School, Adelaide, SA, Australia.; Freemasons Foundation Centre for Men's Health, Adelaide, SA, Australia.; Flinders Health and Medical Research Institute, Flinders University, Bedford Park, South Australia, Australia., Swinnen JV; Department of Oncology, Laboratory of Lipid Metabolism and Cancer, KU Leuven, Leuven, Belgium. lisa.butler@adelaide.edu.au j.swinnen@kuleuven.be., Butler LM; University of Adelaide Medical School, Adelaide, SA, Australia. lisa.butler@adelaide.edu.au j.swinnen@kuleuven.be.; Freemasons Foundation Centre for Men's Health, Adelaide, SA, Australia.; South Australian Health and Medical Research Institute, Adelaide, SA, Australia.

Publikováno v: Cancer research [Cancer Res] 2021 Apr 01; Vol. 81 (7), pp. 1704-1718. Date of Electronic Publication: 2021 Feb 05.

Combining Transcriptomics and Proteomics to Screen Candidate Genes Related to Bovine Birth Weight.

Autor: Wang, Xiuyuan¹ (AUTHOR), Liu, Ruili¹ (AUTHOR), Chen, Zhenpeng¹ (AUTHOR), Zhang, Renzheng¹ (AUTHOR), Mei, Yanfang¹ (AUTHOR), Miao, Xiuping¹ (AUTHOR), Bai, Xuejin^1,2 (AUTHOR), Dong, Yajuan^1,2 (AUTHOR) hnzy@qau.edu.cn

Publikováno v: Animals (2076-2615). Sep2024, Vol. 14 Issue 18, p2751. 18p.

Complete genome sequence and the expression pattern of plasmids of the model ethanologen Zymomonas mobilis ZM4 and its xylose-utilizing derivatives 8b and 2032.

Autor: Yang S; 1Hubei Collaborative Innovation Center for Green Transformation of Bio-resources, Environmental Microbial Technology Center of Hubei Province, Hubei Key Laboratory of Industrial Biotechnology, College of Life Sciences, Hubei University, Wuhan, 430062 China.; 2DOE-National Bioenergy Center, National Renewable Energy Laboratory (NREL), Golden, CO 80401 USA., Vera JM; 3DOE-Great Lakes Bioenergy Research Center (GLBRC), University of Wisconsin-Madison, Madison, WI USA., Grass J; 3DOE-Great Lakes Bioenergy Research Center (GLBRC), University of Wisconsin-Madison, Madison, WI USA., Savvakis G; 4Department of Genetics & Biotechnology, Faculty of Biology, National and Kapodistrian University of Athens (NKUA), Panepistimiopolis, 15701 Athens, Greece., Moskvin OV; 3DOE-Great Lakes Bioenergy Research Center (GLBRC), University of Wisconsin-Madison, Madison, WI USA., Yang Y; 1Hubei Collaborative Innovation Center for Green Transformation of Bio-resources, Environmental Microbial Technology Center of Hubei Province, Hubei Key Laboratory of Industrial Biotechnology, College of Life Sciences, Hubei University, Wuhan, 430062 China., McIlwain SJ; 3DOE-Great Lakes Bioenergy Research Center (GLBRC), University of Wisconsin-Madison, Madison, WI USA., Lyu Y; 3DOE-Great Lakes Bioenergy Research Center (GLBRC), University of Wisconsin-Madison, Madison, WI USA.; 8Present Address: China Three Gorges University, Yichang, 443002 Hubei China., Zinonos I; 4Department of Genetics & Biotechnology, Faculty of Biology, National and Kapodistrian University of Athens (NKUA), Panepistimiopolis, 15701 Athens, Greece., Hebert AS; 3DOE-Great Lakes Bioenergy Research Center (GLBRC), University of Wisconsin-Madison, Madison, WI USA., Coon JJ; 3DOE-Great Lakes Bioenergy Research Center (GLBRC), University of Wisconsin-Madison, Madison, WI USA., Bates DM; 3DOE-Great Lakes Bioenergy Research Center (GLBRC), University of Wisconsin-Madison, Madison, WI USA., Sato TK; 3DOE-Great Lakes Bioenergy Research Center (GLBRC), University of Wisconsin-Madison, Madison, WI USA., Brown SD; 5DOE-BioEnergy Science Center, Oak Ridge National Laboratory (ORNL), Oak Ridge, TN 37831 USA.; 6DOE-Biosciences Division, Oak Ridge National Laboratory (ORNL), Oak Ridge, TN 37831 USA.; Present Address: LanzaTech, Inc., Skokie, IL 60077 USA., Himmel ME; 7DOE-Biosciences Center, National Renewable Energy Laboratory (NREL), Golden, CO 80401 USA., Zhang M; 2DOE-National Bioenergy Center, National Renewable Energy Laboratory (NREL), Golden, CO 80401 USA., Landick R; 3DOE-Great Lakes Bioenergy Research Center (GLBRC), University of Wisconsin-Madison, Madison, WI USA., Pappas KM; 4Department of Genetics & Biotechnology, Faculty of Biology, National and Kapodistrian University of Athens (NKUA), Panepistimiopolis, 15701 Athens, Greece., Zhang Y; 3DOE-Great Lakes Bioenergy Research Center (GLBRC), University of Wisconsin-Madison, Madison, WI USA.

Publikováno v: Biotechnology for biofuels [Biotechnol Biofuels] 2018 May 02; Vol. 11, pp. 125. Date of Electronic Publication: 2018 May 02 (Print Publication: 2018).

Anticancer efficacy of the hypoxia-activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma.

Autor: Liapis V; Discipline of Surgery, Breast Cancer Research Unit, Basil Hetzel Institute and Centre for Personalised Cancer Medicine, University of Adelaide, Woodville, South Australia, Australia., Zysk A; Discipline of Surgery, Breast Cancer Research Unit, Basil Hetzel Institute and Centre for Personalised Cancer Medicine, University of Adelaide, Woodville, South Australia, Australia., DeNichilo M; Vascular Biology and Cell Trafficking Laboratory, Centre for Cancer Biology, University of South Australia, Adelaide, South Australia, Australia., Zinonos I; Discipline of Surgery, Breast Cancer Research Unit, Basil Hetzel Institute and Centre for Personalised Cancer Medicine, University of Adelaide, Woodville, South Australia, Australia., Hay S; Discipline of Surgery, Breast Cancer Research Unit, Basil Hetzel Institute and Centre for Personalised Cancer Medicine, University of Adelaide, Woodville, South Australia, Australia., Panagopoulos V; Discipline of Surgery, Breast Cancer Research Unit, Basil Hetzel Institute and Centre for Personalised Cancer Medicine, University of Adelaide, Woodville, South Australia, Australia., Shoubridge A; Discipline of Surgery, Breast Cancer Research Unit, Basil Hetzel Institute and Centre for Personalised Cancer Medicine, University of Adelaide, Woodville, South Australia, Australia., Difelice C; Discipline of Surgery, Breast Cancer Research Unit, Basil Hetzel Institute and Centre for Personalised Cancer Medicine, University of Adelaide, Woodville, South Australia, Australia., Ponomarev V; Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York., Ingman W; Discipline of Surgery, School of Medicine at The Queen Elizabeth Hospital, University of Adelaide, Woodville, Australia.; Robinson Research Institute, University of Adelaide, Adelaide, Australia., Atkins GJ; Discipline of Orthopaedics and Trauma, University of Adelaide, Adelaide, South Australia, Australia., Findlay DM; Discipline of Orthopaedics and Trauma, University of Adelaide, Adelaide, South Australia, Australia., Zannettino ACW; School of Medical Sciences, Myeloma Research Laboratory Cancer Theme, South Australian Health and Medical Research Institute (SAHMRI), Faculty of Health Science, University of Adelaide, Adelaide, Australia., Evdokiou A; Discipline of Surgery, Breast Cancer Research Unit, Basil Hetzel Institute and Centre for Personalised Cancer Medicine, University of Adelaide, Woodville, South Australia, Australia.

Publikováno v: Cancer medicine [Cancer Med] 2017 Sep; Vol. 6 (9), pp. 2164-2176. Date of Electronic Publication: 2017 Aug 10.

Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment.

Autor: Panagopoulos V; Discipline of Surgery, Breast Cancer Research Unit, Basil Hetzel Institute and Centre for Personalised Cancer Medicine, University of Adelaide, Adelaide, SA, Australia., Leach DA; Discipline of Surgery, Breast Cancer Research Unit, Basil Hetzel Institute and Centre for Personalised Cancer Medicine, University of Adelaide, Adelaide, SA, Australia., Zinonos I; Discipline of Surgery, Breast Cancer Research Unit, Basil Hetzel Institute and Centre for Personalised Cancer Medicine, University of Adelaide, Adelaide, SA, Australia., Ponomarev V; Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA., Licari G; Discipline of Surgery, Breast Cancer Research Unit, Basil Hetzel Institute and Centre for Personalised Cancer Medicine, University of Adelaide, Adelaide, SA, Australia., Liapis V; Discipline of Surgery, Breast Cancer Research Unit, Basil Hetzel Institute and Centre for Personalised Cancer Medicine, University of Adelaide, Adelaide, SA, Australia., Ingman WV; Discipline of Surgery, Breast Cancer Research Unit, Basil Hetzel Institute and Centre for Personalised Cancer Medicine, University of Adelaide, Adelaide, SA, Australia., Anderson P; Australian Craniofacial Unit, Women's and Children's Health Network, Adelaide, SA, Australia., DeNichilo MO; Discipline of Surgery, Breast Cancer Research Unit, Basil Hetzel Institute and Centre for Personalised Cancer Medicine, University of Adelaide, Adelaide, SA, Australia., Evdokiou A; Discipline of Surgery, Breast Cancer Research Unit, Basil Hetzel Institute and Centre for Personalised Cancer Medicine, University of Adelaide, Adelaide, SA, Australia.

Publikováno v: International journal of oncology [Int J Oncol] 2017 Apr; Vol. 50 (4), pp. 1191-1200. Date of Electronic Publication: 2017 Feb 20.